EMA Broadens Imvanex Vaccine Use to Teens as Mpox Cases Rise ...Middle East

Medscape - News
With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( EMA Broadens Imvanex Vaccine Use to Teens as Mpox Cases Rise )

Apple Storegoogle play

Also on site :